RecruitingPhase 2NCT05576974

A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY)

Studying Squamous cell carcinoma of oral cavity and lip

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Texas Southwestern Medical Center
Intervention
Pegsitacianine(drug)
Enrollment
120 enrolled
Eligibility
18-99 years · All sexes
Timeline
20242027

Study locations (1)

Collaborators

National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05576974 on ClinicalTrials.gov

Other trials for Squamous cell carcinoma of oral cavity and lip

Additional recruiting or active studies for the same condition.

See all trials for Squamous cell carcinoma of oral cavity and lip

← Back to all trials